Deuterium Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-72,091	Closed	-$79.3K	–	39
2024 Q2	$79.3K	Sell	72,091 -7,902	-10%	-$8.69K	0.13%	45
2024 Q1	$99.2K	Buy	+79,993	New	+$99.2K	0.18%	40